Biotechnology
The 26th China Yangling Agricultural High-tech Achievements Expo will begin on October 22
YANGLING, China, Oct. 16, 2019 /PRNewswire/ -- On October 15, over ten international reporters, representing, among others, the European Pressphoto Agency, the Colpisa News Agency, the Korean Central News Agency, Radio-Television Slovenia, and the Republic of Korea's "Asian Economy", visited Yan...
2019-10-16 19:28
1137
WuXi AppTec Research Service Division and BioSolveIT Introduce GalaXi®, a Vast New Chemical Space of Tangible Molecules
SHANGHAI and CAMBRIDGE, Massachusetts and SANKT AUGUSTIN, Germany, Oct. 10, 2019 /PRNewswire/ -- WuXi AppTec Research Service Division and BioSolveIT today launched a new virtual chemical space called GalaXi®. Largely built from WuXi AppTec's library of novel drug-like scaffolds, GalaXi® offers a...
2019-10-11 08:02
7699
Medicago's New Drug Submission accepted for scientific review by Health Canada: An important step for Medicago towards commercialization of its innovative influenza vaccine
QUEBEC CITY, Oct. 3, 2019 /PRNewswire/ -- Medicago, a biotechnology company and global leader in the development and production of plant-derived vaccines with headquarters inQuebec City, announces today that Health Canada accepted for scientific review its New Drug Submission (NDS) for a plant-ba...
2019-10-03 06:30
1402
Kinoxis Therapeutics Awarded NIH HEAL Initiative Grant to Advance KNX100 for the Treatment of Opioid Withdrawal
MELBOURNE, Australia and SYDNEY, Sept. 29, 2019 /PRNewswire/ -- Kinoxis Therapeutics Pty Ltd, a pre-clinical stage biotechnology company developing novel therapies for substance use disorders and other central nervous system disorders, has been awarded a major grant from the US National Institut...
2019-09-30 05:00
974
Preclincal Results of Baoyuan's Next-Generation ROS1/NTRK Inhibitor AB-106 Published in Nature Communications
HANGZHOU, China, Sept. 25, 2019 /PRNewswire/ -- The preclinical results of AB-106 (original code: DS-6051b), an investigational next generation ROS1/NTRK dual inhibitor exclusively in-licensed by AnHeart Therapeutics, a wholly-owned subsidiary of Baoyuan Biopharmaceuticals Technology (Hangzhou) C...
2019-09-25 18:35
2205
China Biologic Forms Special Committee to Review "Going Private" Proposal
BEIJING, Sept. 24, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that its board of directors (the "Board") has formed a special committee (th...
2019-09-24 20:00
12221
CARsgen Announces Investigational CAR-T Therapy CT053 Granted PRIME Eligibility by the European Medicines Agency
SHANGHAI, Sept. 23, 2019 /PRNewswire/ -- CARsgen Therapeutics Inc., a clinical-stage biopharmaceutical company today announced the European Medicines Agency (EMA) has granted PRIority MEdicines (PRIME) eligibility to its investigational CAR-T cell therapy fully human anti-BCMA (B Cell Maturation ...
2019-09-23 18:00
5659
China Biologic Announces Receipt of Preliminary Non-Binding "Going Private" Proposal
BEIJING, Sept. 18, 2019 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced that its board of directors (the "Board") has received a preliminary non-bin...
2019-09-19 04:01
11711
Origin Agritech Entered Strategic Collaboration Agreement with Inova Genetica Ltda
BEIJING, Sept. 17, 2019 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology and rural e-commerce company, today announced that the Company has entered into a collaboration agreement with Inova Genética Ltda (INOVA), a member of the Wehrmann G...
2019-09-17 20:00
6351
Academician discusses healthcare advances over 70 years
BEIJING, Sept. 16, 2019 /PRNewswire/ -- A news report by China Daily discussing healthcare advances over 70 years inChina:   The life expectancy of Chinese people has risen from just 35 years to over 77 sincethe People's Republic of China was founded, owing to great efforts of ...
2019-09-16 19:37
1595
Kazia wins ANZLF Trans-Tasman Innovation & Growth Award and reports new data from clinical trial in childhood brain cancer
SYDNEY, Sept. 13, 2019 /PRNewswire/ -- Australian oncology-focused biotech company Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA) is pleased to announce that it has been named as a winner in the 2019 ANZLF Trans-Tasman Innovation & Growth Awards. The Awards celebrate the innovation, growth and ...
2019-09-13 20:00
7353
St Jude Study of GDC-0084 in DIPG Successfully Completes First Stage; Second Part of Study Now Underway
SYDNEY, Sept. 12, 2019 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that St Jude Children's Research Hospital has successfully completed the first stage of its ongoing phase I study of Kazia's in...
2019-09-12 21:10
7433
WuXi AppTec Launches DNA Encoded Library (DEL) Service Package "DELight" to Expedite Early Drug Discovery
SHANGHAI and BOSTON, Sept. 3, 2019 /PRNewswire/ -- WuXi AppTec today announced its launch of DELight, a novel DNA Encoded Library (DEL) service package, providing cost-effective and efficient hit finding services to expedite early drug discovery and bring new medicines to patients faster. DELigh...
2019-09-04 08:00
1804
Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2020
1Q20 Added 20,815 New Subscribers Revenues Up 16.9% YoY to RMB273.4 Million ($39.8 Million ) Gross Profit Up 19.4% YoY to RMB227.6 million ($33.2 million) Operating Income Up 17.8% YoY to RMB112.4 Million ($16.4 Million) Non-GAAP Operating Income Up 15.0% YoY to RMB...
2019-08-28 04:16
8389
Origin Agritech Entered Collaboration Agreement with Biotechnology Research Institute of Chinese Academy of Agriculture Sciences to Speed up Commercialization of GM Traits in China
BEIJING, Aug. 27, 2019 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology and rural e-commerce company, today announced that the Company has entered into a collaboration agreement with Biotechnology Research Institute (BRI) of Chinese Academ...
2019-08-27 20:00
4403
WuXi Biologics Reports Outstanding Interim Results
* 52.4% Year-on-Year Revenue Growth to RMB1,607.1 Million * Net Profit Increased 80.1% Year-on-Year to RMB449.5 Million * Gross Profit Margin, Net Profit Margin and Adjusted Net Profit Margin All Record High * Total Backlog Surged to US$4.6 Billion * 32 New Integrated Projects Including 1...
2019-08-19 22:09
10815
WuXi AppTec Reports First Half 2019 Interim Results
* Revenue Accelerated 33.7% Year-Over-Year to RMB 5,894 Million * Gross Profit Up 30.0% Year-Over-Year to RMB 2,284 million[1] * Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 32.0% Year-Over-Year toRMB 1,179 Million * Small Molecule CDMO/CMO Pipeline has Grown to 800...
2019-08-19 19:20
5229
Abstract on CStone's CS1001-101 trial accepted for poster presentation at ESMO 2019 Annual Congress
SUZHOU, China, Aug. 19, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that an abstract on the company's ongoing CS1001-101 Phase Ib clinical study has been accepted for poster presentation at the upcoming European Society for Medical Oncology (ESMO) 2019 Annua...
2019-08-19 13:50
6089
New Publication Shows Different Result of Risk Classification between GenesWell BCT and Oncotype DX in Breast Cancer Patients 50 Years Old or Younger.
SEOUL, South Korea, Aug. 12, 2019 /PRNewswire/ -- Gencurix, Inc., a company dedicated in development and market of innovative molecular diagnostics, announced the publication of a new study onFrontiers in Oncology comparing GenesWell™ BCT, a prognostic multigene test, with Genomic Health's Oncoty...
2019-08-12 21:00
2458
Samsung BioLogics Implements Large Scale N-1 Perfusion for Commercial Application
INCHEON, South Korea, Aug. 12, 2019 /PRNewswire/ -- Samsung BioLogics (SBL) has successfully performed N-1 (3,000L) perfusion with Alternating Tangential Flow (ATF) device to supply the 15,000L commercial production process in the Plant 3 facility at its manufacturing site in Songdo, S. Korea rec...
2019-08-12 19:00
2015
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 287 media titles]
2024-04-18 21:26
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25
Animated Life in Yunnan
[Picked up by 281 media titles]
2024-04-18 14:00
Most Read
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
9172
With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
2024-04-18 21:26
8839
Animated Life in Yunnan
2024-04-18 14:00
7829
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
7751